Bone‐Targeted Biomimetic Nanogels Re‐Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis
Small · 2024-02 · 20 (6)
DOI: 10.1002/smll.202303494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 04.10.2023. Verfasst von Yongzhi Cui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. …. Hauptthemen laut MEDLINE: Osteoclasts, Osteoporosis, Postmenopausal. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Insufficient bone formation and excessive bone resorption caused by estrogen deficiency are the major factors resulting in the incidence of postmenopausal osteoporosis (PMOP). The existing drugs usually fail to re‐establish the osteoblast/osteoclast balance from both sides and generate side‐effects owing to the lack of bone‐targeting ability. Here, engineered cell‐membrane‐coated nanogels PNG@mR&C capable of scavenging receptor activator of nuclear factor‐κB ligand (RANKL) and responsively releasing therapeutic PTH 1–34 in the bone microenvironment are prepared from RANK and CXCR4 overexpressed bone mesenchymal stem cell (BMSC) membrane‐coated chitosan biopolymers. The CXCR4 on the coated‐membranes confer bone‐targeting ability, and abundant RANK effectively absorb RANKL to inhibit osteoclastogenesis. Meanwhile, the release of PTH 1–34 triggered by osteoclast‐mediated acid microenvironment promote osteogenesis. In addition, the dose and frequency are greatly reduced due to the smart release property, prolonged circulation time, and bone‐specific accumulation. Thus, PNG@mR&C exhibits satisfactory therapeutic effects in the ovariectomized (OVX) mouse model. This study provides a new paradigm re‐establishing the bone metabolic homeostasis from multitargets and shows great promise for the treatment of PMOP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. China.
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P. R. China.
- Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, P. R. China.
- Department of Thyroid and Breast, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P. R. China.
- Department of Orthopaedics, The Third Hospital, Hebei Medical University, Shijiazhuang, Hebei, 050051, P. R. China.
- Department of Spine Surgery, Changzheng hospital, Naval Medical University, Shanghai, 200003, P. R. China.
ORCID-Profile: Yongzhi Cui, Dehao Fu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cui, Y., Lv, B., Li, Z., Ma, C., Gui, Z., Geng, Y., Liu, G., Sang, L., Xu, C., Min, Q., Kong, L., Zhang, Z., Liu, Y., Qi, X., & Fu, D. (2024). Bone‐Targeted Biomimetic Nanogels Re‐Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis. Small, 20(6). https://doi.org/10.1002/smll.202303494
Vancouver
Cui Y, Lv B, Li Z, Ma C, Gui Z, Geng Y, et al. Bone‐Targeted Biomimetic Nanogels Re‐Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis. Small. 2024;20(6). doi:10.1002/smll.202303494
BibTeX
@article{Cui2024,
author = {Cui, Yongzhi and Lv, Bin and Li, Zhongying and Ma, Chunming and Gui, Zhengwei and Geng, Yongtao and Liu, Guohui and Sang, Linchao and Xu, Chen and Min, Qi and Kong, Li and Zhang, Zhiping and Liu, Yang and Qi, Xiangbei and Fu, Dehao},
title = {Bone‐Targeted Biomimetic Nanogels Re‐Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis},
journal = {Small},
year = {2024},
volume = {20},
number = {6},
doi = {10.1002/smll.202303494}
}
EUVIMED